Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07BUH
|
|||
| Former ID |
DIB009849
|
|||
| Drug Name |
Efbemalenograstim
|
|||
| Synonyms |
F-627; Recombinant human G-CSF dimer (neutropenia), Generon (Shanghai) Corporation Ltd
Click to Show/Hide
|
|||
| Indication | Neutropenia [ICD-11: 4B00.0; ICD-9: 288] | Approved | [1] | |
| Company |
Evive
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Granulocyte colony-stimulating factor (CSF3) | Target Info | Modulator | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| PI3K-Akt signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| Hematopoietic cell lineage | ||||
| Malaria | ||||
| NetPath Pathway | IL1 Signaling Pathway | |||
| TNFalpha Signaling Pathway | ||||
| TCR Signaling Pathway | ||||
| WikiPathways | Cytokines and Inflammatory Response | |||
| Hematopoietic Stem Cell Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761134 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.